What is the equity of Cipher Pharmaceuticals this year?
Cipher Pharmaceuticals has equity of 80.52 M USD this year.
Cipher Pharmaceuticals Equity 2024
Cipher Pharmaceuticals Equity
80.52 M USD
Ticker
CPH.TO
ISIN
CA17253X1050
WKN
A0B85L
In 2024, Cipher Pharmaceuticals's equity was 80.52 M USD, a 25.62% increase from the 64.1 M USD equity in the previous year.
Cipher Pharmaceuticals Aktienanalyse
What does Cipher Pharmaceuticals do?
Cipher Pharmaceuticals Inc. is a Canadian pharmaceutical company specializing in the development, marketing, and distribution of medications. The company was founded in 1999 and is headquartered in Oakville, Ontario, Canada. Translator note: The translation provided above is a faithful rendering of the German text into English. Cipher Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Cipher Pharmaceuticals's Equity
Cipher Pharmaceuticals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Cipher Pharmaceuticals's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Cipher Pharmaceuticals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Cipher Pharmaceuticals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Cipher Pharmaceuticals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Cipher Pharmaceuticals stock
What was the equity of Cipher Pharmaceuticals compared to the previous year?
The equity of Cipher Pharmaceuticals has increased/decreased by 25.62% increased compared to the previous year.
What impact does a high equity have on investors of Cipher Pharmaceuticals?
A high equity is advantageous for investors of Cipher Pharmaceuticals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Cipher Pharmaceuticals?
A low equity can be a risk for investors of Cipher Pharmaceuticals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Cipher Pharmaceuticals affect the company?
An increase in equity of Cipher Pharmaceuticals can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Cipher Pharmaceuticals affect the company?
A reduction in equity of Cipher Pharmaceuticals can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Cipher Pharmaceuticals?
Some factors that can affect the equity of Cipher Pharmaceuticals include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Cipher Pharmaceuticals so important for investors?
The equity of Cipher Pharmaceuticals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Cipher Pharmaceuticals take to change the equity?
To change equity, Cipher Pharmaceuticals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Cipher Pharmaceuticals pay?
Over the past 12 months, Cipher Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cipher Pharmaceuticals is expected to pay a dividend of 0 USD.
What is the dividend yield of Cipher Pharmaceuticals?
The current dividend yield of Cipher Pharmaceuticals is .
When does Cipher Pharmaceuticals pay dividends?
Cipher Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Cipher Pharmaceuticals?
Cipher Pharmaceuticals paid dividends every year for the past 0 years.
What is the dividend of Cipher Pharmaceuticals?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Cipher Pharmaceuticals located?
Cipher Pharmaceuticals is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cipher Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cipher Pharmaceuticals from 9/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/22/2024.
When did Cipher Pharmaceuticals pay the last dividend?
The last dividend was paid out on 9/22/2024.
What was the dividend of Cipher Pharmaceuticals in the year 2023?
In the year 2023, Cipher Pharmaceuticals distributed 0 USD as dividends.
In which currency does Cipher Pharmaceuticals pay out the dividend?
The dividends of Cipher Pharmaceuticals are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cipher Pharmaceuticals
Our stock analysis for Cipher Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cipher Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Cipher Pharmaceuticals Revenue
- Cipher Pharmaceuticals Net Income
- Cipher Pharmaceuticals P/E
- Cipher Pharmaceuticals P/S
- Cipher Pharmaceuticals EBIT
- Cipher Pharmaceuticals Dividend
- Cipher Pharmaceuticals Stocks
- Cipher Pharmaceuticals Market capitalization
- Cipher Pharmaceuticals Debt
- Cipher Pharmaceuticals Liabilities
- Cipher Pharmaceuticals Equity
- Cipher Pharmaceuticals AAQS
- Cipher Pharmaceuticals Employees
- Cipher Pharmaceuticals ROE
- Cipher Pharmaceuticals ROA
- Cipher Pharmaceuticals ROCE
